Sfoglia per AUTORE
XU Y
Collezione AOU Città della Salute di Torino
Items : 2
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2023 Nov 30;12(11):2229-2244. doi: 10.21037/tlcr-23-577. Epub 2023 Oct 26.
2023
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Chen X; Zhang S; Gu Y; Tang Y; Mu X; Qin J; Yang X; He M; Liu Y; Zhong W; Gao J; Chen M; Zhao J; Gao X; Liu J; Zhang H; Shi Y; Zhao D; Shen F; Liu X; Zhang D; Pang L; Meng Q; Guo Y; Zhang Y; Li W; Xing P; Cheng Y; Xin T; et alii...
Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma. in Haematologica / Haematologica. 2020 Jan 31;105(2):e72-e75. doi: 10.3324/haematol.2019.220475. Print 2020.
2020
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Nowakowski GS; Chiappella A; Witzig TE; Scott DW; Spina M; Gascoyne RD; Zhang L; Russo J; Kang J; Zhang J; Xu Y; Vitolo U;